Abbott Laboratories Insider Trading
Every director, officer and 10% holder of Abbott Laboratories has to report each trade in its stock within two business days of making it. This is those filings.
ABT on carbonthat →Purchases and sales
Open-market trades only — the lines where someone chose to buy or sell at the going price.
| Insider | Action | Value |
|---|---|---|
| John A. McCoy Jr.VICE PRESIDENT AND CONTROLLER2026-09-0227 shat $109.54 | Sale | $3K |
| Robert B FordCHAIRMAN AND CEO2026-08-25218.5K shat $115.57 | Sale | $25.3M |
| Robert B FordCHAIRMAN AND CEO2026-08-25180.3K shat $116.19 | Sale | $20.9M |
| Louis H. MorroneEXECUTIVE VICE PRESIDENT2026-08-115.9K shat $109.83 | Sale | $642.5K |
Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
More on ABT
Follow Abbott Laboratories (ABT) by email
New trades in Abbott Laboratories (ABT) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.